Concepedia

Robert Justice

RJ

47

Publications

7K

Citations

40

H-Index

1979

Active since

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

United States Department of Health and Human Services

Robert Justice is an author at Center for Drug Evaluation and Research specializing in oncology, medicine, and cancer therapeutics.

Top concepts

MedicineOncologyCancer TherapyPharmacologyCancer ResearchPharmacotherapyClinical TrialsRadiation OncologyHealthPathology

Publications per year

1979–2015

47

Publications

47

FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma

Bhupinder Mann, John R. Johnson, Martin H. Cohen et al. · The Oncologist · 2007 · 1.3K citations · Full text

Approval Summary: Imatinib Mesylate in the Treatment of Metastatic and/or Unresectable Malignant Gastrointestinal Stromal Tumors

Martin H. Cohen, Ann T. Farrell, Robert Justice et al. · The Oncologist · 2009 · 428 citations · Full text

Surgical Oncology, Imatinib Mesylate, Gastrointestinal Oncology +14

FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer

Laleh Amiri‐Kordestani, Gideon M. Blumenthal, Qiang Xu et al. · Clinical Cancer Research · 2014 · 336 citations

Metastatic Breast Cancer, Independent Review Committee, Breast Oncology +13

Bortezomib for the Treatment of Mantle Cell Lymphoma

Robert C. Kane, Ramzi Dagher, Ann T. Farrell et al. · Clinical Cancer Research · 2007 · 330 citations · Full text

FDA Drug Approval Summary: Lapatinib in Combination with Capecitabine for Previously Treated Metastatic Breast Cancer That Overexpresses HER-2

Qin Ryan, Amna Ibrahim, Martin H. Cohen et al. · The Oncologist · 2008 · 303 citations · Full text

Rows per page

1–5 of 47